<div dir="ltr"><div class="gmail_default" style="font-family:tahoma,sans-serif;font-size:small">FYI </div><div><div dir="ltr" class="gmail_signature" data-smartmail="gmail_signature"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div>Stacie</div><div><br></div><div><b>Stacie Leap</b><br></div><div><a href="mailto:stacie.leap@gmail.com" target="_blank">stacie.leap@gmail.com</a> | 215.776.6741</div></div></div></div></div></div></div></div></div></div></div></div></div></div><br><br><div class="gmail_quote"><div dir="ltr" class="gmail_attr">---------- Forwarded message ---------<br>From: <strong class="gmail_sendername" dir="auto">Philadelphia Department of Public Health</strong> <span dir="auto"><<a href="mailto:health.notifications@phila.gov">health.notifications@phila.gov</a>></span><br>Date: Mon, May 23, 2022 at 11:00 AM<br>Subject: PDPH Advisory – COVID-19 Pfizer-BioNTech Single Booster for Children between 5 to 11 years<br>To: <a href="mailto:stacie.leap@gmail.com">stacie.leap@gmail.com</a> <<a href="mailto:stacie.leap@gmail.com">stacie.leap@gmail.com</a>><br></div><br><br> <u></u>
<div style="font-family:Helvetica,Arial;line-height:1.5">
<div>
<div>
</div>
<div>
<p> <span style="font-size:12pt">The Philadelphia Department of Public Health has just released a <strong>Health Advisory</strong> regarding updates to COVID-19 booster dose recommendations for children ages 5-11. It is available from <a href="https://hip.phila.gov" rel="noopener" target="_blank">https://hip.phila.gov</a>, is appended to this email and is attached as a PDF document. To read this attachment, you will need the Adobe Reader software, which can be downloaded at no cost from <a href="http://tinyurl.com/6ip" rel="noopener" target="_blank">http://tinyurl.com/6ip</a>.</span><br><br><span style="font-size:12pt">If you have any questions or problems, please contact the Philadelphia Department of Public Health at <a href="mailto:publichealthpreparedness@phila.gov" rel="noopener" target="_blank">publichealthpreparedness@phila.gov</a>.</span><br><br><span style="font-size:12pt">To report a disease or condition to the Philadelphia Department of Public Health, call 215-685-6748 during business hours (8:30AM to 5:00PM Monday-Friday). If the disease or condition requires immediate notification and it is after normal business hours, call 215-686-4514 and ask to speak with the contact for the Division of Disease Control.</span><br><br><span style="font-size:12pt">To update your contact information for the Health Alert Network or to register to receive health alerts and newsletters from PDPH, reply directly to this email or complete a registration form at <a href="https://hip.phila.gov/HealthAlerts/SignUpHealthAlerts" rel="noopener" target="_blank">https://hip.phila.gov/HealthAlerts/SignUpHealthAlerts</a></span><br><br><span style="font-size:12pt">Philadelphia Department of Public Health</span><br><em><span style="font-size:12pt">Health Advisory</span></em><br><strong><span style="font-size:12pt">COVID-19 Pfizer-BioNTech Single Booster for Children between 5 to 11 Years</span></strong><br><span style="font-size:12pt">May 23, 2022</span><br><br><strong><span style="font-size:12pt">Summary Points:</span></strong><br>
</p><ul>
<li><span style="font-family:Arial,sans-serif;font-size:12pt">Children between ages 5 through 11 years should receive the Pfizer-BioNTech single booster at least 5 months after completing the primary series.</span></li>
<li><span style="font-size:12pt">FDA has evaluated the safety and effectiveness data and determined that the Pfizer-BioNTech single booster outweighs its known and potential risks.</span></li>
<li><span style="font-size:12pt">Common side effects profiles of the Pfizer-BioNTech single booster are similar to the side effects from the primary series.</span></li>
<li><span style="font-size:12pt">If children are eligible to receive other vaccinations, they may receive the COVID-19 and other vaccines during the same visit. </span></li>
</ul>
<p><span style="font-size:12pt;color:black;background:white">The CDC and FDA recommend a single booster dose of Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age <strong>at least 5 months</strong> after completing the primary series or the additional dose for those who are immunocompromised. The CDC and the FDA have determined that benefits will outweigh any known and potential risks. </span></p>
<p><span style="font-size:12pt;font-family:Arial,sans-serif;color:black;background:white">Emerging data suggests that vaccine effectiveness against COVID-19 wanes with increasing time after the second dose of vaccine in all populations who are eligible to receive the COVID-19 vaccines.</span></p>
<p><span style="font-size:12pt;color:black;background:white">Support for authorization is based on immune response data from a subset of study participants (children between ages 5 to 11 years) who received a Pfizer-BioNTech booster dose 7 to 9 months after completing the two-dose primary series. Antibody level against COVID-19 one month after the booster dose was compared to the level before the booster dose and found to be increased. </span></p>
<p><span style="font-size:12pt;color:black;background:white">In addition to efficacy data, FDA gathered the safety information from 400 children who received a booster dose at least 5 months (ranging from 5 to 9 months) after completing a two-dose primary series. The most common side effects were injection site pain/redness/swelling, fatigue, headache, muscle/joint pain, chills, and fever. </span></p>
<p><span style="font-size:12pt;color:black;background:white">Pfizer-BioNTech is the only COVID-19 vaccine authorized for children between 5 to 11 years of age. There is no second booster dose authorized for this age group. Children less than 5 years of age are not eligible for any COVID-19 vaccines. </span></p>
<p><span style="font-size:12pt;font-family:Arial,sans-serif;color:black;background:white">People who are 5 years and older may receive the COVID-19 vaccines and other vaccines (i.e., a flu shot) during the same visit. If the child is eligible to receive multiple vaccines at the same visit, each injection should be separated by 1 inch or more.<br><br><strong>Resources:</strong><br></span></p>
<span><span style="font-family:Symbol;color:windowtext;text-decoration:none"><span style="font:7.0pt 'Times New Roman'"> </span></span></span>
<ul>
<li><span style="font-size:12.0pt;line-height:115%"><span style="line-height:115%;font-family:Arial,sans-serif"><a href="https://www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccines-children-teens.html#:~:text=What%20You%20Need%20to%20Know,a%20COVID%2D19%20booster%20shot." target="_blank">COVID-19 Vaccine Recommendations for Children and Teens</a></span></span></li>
<li><span style="font-size:12pt"><a href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-pfizer-biontech-covid-19-vaccine-booster-dose" target="_blank"><span style="line-height:115%;font-family:Arial,sans-serif">COVID-19 Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose to Children 5 through 11 Years</span></a><span style="line-height:115%"></span></span></li>
<li><span style="font-size:12.0pt;line-height:115%"><a href="https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#recommendations" target="_blank"><span style="line-height:115%;font-family:Arial,sans-serif">Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States</span></a></span></li>
</ul>
<p><span style="font-size:12pt;font-family:Arial,sans-serif;color:black;background:white"><br></span></p><p></p>
<div style="margin:30px 0px">
</div>
</div>
<div style="color:#777777;margin-top:20px">
<div style="text-align:center"><font style="font-size:14px;font-family:Arial;color:rgb(255,255,255)"> </font><span><span style="color:rgb(51,51,51);background-color:rgb(255,255,255)"><span style="font-family:Arial"><span style="font-size:14px;font-weight:400;letter-spacing:0.1px;text-align:center">To stop receiving future email notifications from Philadelphia </span><span style="text-align:center;font-size:14px;letter-spacing:0.1px">Department</span><span style="font-size:14px;font-weight:400;letter-spacing:0.1px;text-align:center"> Public Health,</span></span><span style="font-family:Roboto-Regular;font-size:14px;font-weight:400;letter-spacing:0.1px;text-align:center"> </span></span><font color="#040404" style="font-family:Arial,Helvetica,sans-serif;font-size:14px;font-weight:bold"><a href="https://notifications.everbridge.net/unsubscription/email/pojUHECtuGI3GcJ3Fyi3pMOICw1qiv2UU6YJP_LfAaPzsNgG1GYzDZqhzgyfDIfeifHNh9HoRbGWW6ELO0XJMCd6IX8ZVyy2qR0DIX9QZlG7zbnGxQ6OrQI0jbU01tq6N--abV4VfT3bWJQOJhV2MV7E45EyObwxEpBHuv46Y3zsTpw1dDoP34VLn4jh5vJi573kPwp4IMf3UyBigCEw354k7N91YRW0csrqRUY93FE9H4tHWjBpc2TCRK8zhGe3JGCoC8IXanJMjuJIsG3tBpQUF0KkwVKWY1eogRYpsmXu_y7POxa6diWamtCGgTNKmjGkwAjfWb5-kPXVF3Wuxw-4UK7kGNxaOt87S49XrZl4V-XXYRuceV8988WcgUBOutGH9VNZGeDfB6Hyjdp6FenPO38fQ1zdFjNT1FrdVy1UJu2QZ_2cU5vPRLvJ37L2kmTIy6gWIB-1tQ-8glcuRGS6UldsFBnpSrJnf-OYMawWM2XR_UoZQdjr_uQccHt2NwIZP8xozGiTJbJClDfrDUjQegUiI0kdU8zFP_w3vf0=?language=en-US" style="color:#0000ee;font-weight:bold;text-decoration:underline" target="_blank"><span style="color:#0000ee;text-decoration:underline">Unsubscribe Here</span></a>. </font><font color="#040404" style="font-family:Arial,Helvetica,sans-serif;font-size:14px">This will unsubscribe your email address from all future email contact. </font></span></div></div>
</div>
</div>
</div></div>